Zobrazeno 1 - 10
of 515
pro vyhledávání: '"YANXIANG CHENG"'
Autor:
Wei Tan, Gantao Chen, Qinyu Ci, Zhimin Deng, Ran Gu, Dongyong Yang, Fangfang Dai, Hua Liu, Yanxiang Cheng
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-16 (2024)
Abstract Patients with advanced and recurrent cervical cancer often lack satisfactory treatment outcomes. Thus, it is necessary to seek reliable biomarkers that provide the ability to identify the disease at an early stage and predict the patient pro
Externí odkaz:
https://doaj.org/article/40ac6bb372014991aa652eb058050cf9
Publikováno v:
Heliyon, Vol 10, Iss 15, Pp e35457- (2024)
Aim: Ovarian cancer (OC) is the most lethal gynecological malignancy, which seriously affects the prognosis and life quality of female patients. Therefore, new therapeutic targets and treatments are urgently needed. Methods: Expression levels of miR-
Externí odkaz:
https://doaj.org/article/efc8cc1341c0441eb787164e723e85a3
Autor:
Fangfang Dai, Hua Liu, Juan He, Jinglin Wu, Chaoyan Yuan, Ruiqi Wang, Mengqin Yuan, Dongyong Yang, Zhimin Deng, Linlin Wang, Yanqing Wang, Xiao Yang, Huiling Wang, Wei Hu, Yanxiang Cheng
Publikováno v:
Stem Cell Research & Therapy, Vol 15, Iss 1, Pp 1-19 (2024)
Abstract Background Clinically, hormone replacement therapy (HRT) is the main treatment for primary ovarian insufficiency (POI). However, HRT may increase the risk of both breast cancer and cardiovascular disease. Exosomes derived from human umbilica
Externí odkaz:
https://doaj.org/article/fda5067c9a9449608b53d91a670df552
Autor:
Fangfang Dai, Ruiqi Wang, Zhimin Deng, Dongyong Yang, Linlin Wang, Mali Wu, Wei Hu, Yanxiang Cheng
Publikováno v:
Stem Cell Research & Therapy, Vol 14, Iss 1, Pp 1-23 (2023)
Abstract Incidence of premature ovarian failure (POF) is higher with the increase of the pace of life. The etiology of POF is very complex, which is closely related to genes, immune diseases, drugs, surgery, and psychological factors. Ideal animal mo
Externí odkaz:
https://doaj.org/article/55aad76924164944955395db3b59febc
Publikováno v:
Journal of Ovarian Research, Vol 16, Iss 1, Pp 1-18 (2023)
Abstract Ovarian cancer is a highly heterogeneous gynecological malignancy that seriously affects the survival and prognosis of female patients. Single-cell sequencing and transcriptome analysis can effectively characterize tumor heterogeneity to bet
Externí odkaz:
https://doaj.org/article/74cb87ab157a4681a7c0b6d9cd5e1ae0
Publikováno v:
European Journal of Medical Research, Vol 27, Iss 1, Pp 1-23 (2022)
Abstract Background Breast cancer (BC) is a highly malignant and heterogeneous tumor which is currently the cancer with the highest incidence and seriously endangers the survival and prognosis of patients. Aging, as a research hotspot in recent years
Externí odkaz:
https://doaj.org/article/404482b580a441219396c4d07e0fd81a
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
IntroductionSuccessful embryo implantation, is the initiating step of pregnancy, relies on not only the high quality of the embryo but also the synergistic development of a healthy endometrium. Characterization and identification of biomarkers for th
Externí odkaz:
https://doaj.org/article/368fa712c55b4e0caf2890f5db675683
Autor:
Mali Wu, Jie Zhang, Ran Gu, Fangfang Dai, Dongyong Yang, Yajing Zheng, Wei Tan, Yifan Jia, Bingshu Li, Yanxiang Cheng
Publikováno v:
European Journal of Medical Research, Vol 27, Iss 1, Pp 1-10 (2022)
Abstract Polycystic ovarian syndrome (PCOS) is the most common multifactor heterogeneous endocrine and metabolic disease in women of childbearing age. PCOS is a group of clinical syndromes characterized by reproductive disorders, metabolic disorders,
Externí odkaz:
https://doaj.org/article/c21a494412134c4e98e51104b7ebbec3
Autor:
Kunkun Dou, Kuofei Li, Mei Chen, Bolin Zhao, Yuannan Chen, Hao Deng, Xuejing Liu, Chenyang Zhao, Hongmei Zhan, Yuwei Zhang, Chuanjiang Qina, Yanxiang Cheng
Publikováno v:
Journal of Materials Chemistry C; 8/28/2024, Vol. 12 Issue 32, p12444-12450, 7p
Autor:
Zhijie Dai, Ronghua Zhu, Zhifeng Sheng, Guijun Qin, Xianghang Luo, Qun Qin, Chunli Song, Liping Li, Ping Jin, Guoping Yang, Yanxiang Cheng, Danhong Peng, Chong Zou, Lijuan Wang, Jianzhong Shentu, Qin Zhang, Zhe Zhang, Xiang Yan, Pingfei Fang, Qiangyong Yan, Lingfeng Yang, Xiao Fan, Wei Liu, Bo Wu, Rongrong Cui, Xiyu Wu, Yuting Xie, Chang Shu, Kai Shen, Wenhua Wei, Wei Lu, Hong Chen, Zhiguang Zhou
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
SHR-1222, a novel humanized monoclonal antibody targeting sclerostin, has been shown to induce bone formation and decrease bone resorption at a single dose ranging 50–400 mg in our previous phase 1 trial. This study was a randomized, double-blind,
Externí odkaz:
https://doaj.org/article/a89e55f5717f475a9a05befd69d69692